SCHEMBL6469200

SCHEMBL6469200

CC(C)(Cc1ccc(Cl)cc1)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRN P28799 1/20 0.54
SORT1 Q99523 1/20 0.54
PTGES2 Q9H7Z7 8/20 0.54
SLC6A2 P23975 1/20 0.53
HTR2A P28223 1/20 0.53
SLC6A4 P31645 1/20 0.53
HRH1 P35367 1/20 0.53
HTR2B P41595 1/20 0.53
CHRNA4 P43681 1/20 0.53
SLC6A3 Q01959 1/20 0.53
PPARA Q07869 2/20 0.53
PPARG P37231 1/20 0.53
CYP3A4 P08684 4/20 0.49
CYP1A2 P05177 3/20 0.49
CYP2C19 P33261 3/20 0.49
CYP2C9 P11712 2/20 0.49
MAPT P10636 2/20 0.49
KDM4E B2RXH2 1/20 0.49
HPGD P15428 1/20 0.49
TSHR P16473 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11279619 0.94 PTGES2 (0.53) GRNSORT1PTGES2SLC6A2HTR2A
SCHEMBL4328573 0.86 SLC6A4 (0.55) GRNSORT1PTGES2SLC6A2HTR2A
SCHEMBL7470435 0.84 SLC6A4 (0.53) GRNSORT1PTGES2SLC6A2HTR2A
SCHEMBL10383881 0.84 SLC6A4 (0.53) GRNSORT1SLC6A2HTR2ASLC6A4
SCHEMBL10973409 0.84 BLM (0.46) GRNSORT1PTGES2PPARAPPARG
SCHEMBL8082304 0.84 SLC6A4 (0.59) GRNSORT1SLC6A2HTR2ASLC6A4
SCHEMBL27925093 0.83 ESR1 (0.56) GRNSORT1PTGES2PPARAPPARG
SCHEMBL27792993 0.82 PPARA (0.55) GRNSORT1PTGES2SLC6A2HTR2A
SCHEMBL10694426 0.82 SLC6A4 (0.52) GRNSORT1PTGES2SLC6A2HTR2A
SCHEMBL6668736 0.82 BLM (0.52) SLC6A2CYP3A4CYP1A2MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188037-A1 N-(PYRROLIDIN-3-YL OR PIPERIDIN-4-YL)ACETAMIDE DERIVATIVES TAKEDA PHARMACEUTICALS CO (JP) 2025-06-12 US disclosed
CN-119585238-A N- (pyrrolidin-3-yl or piperidin-4-yl) acetamide derivatives 武田药品工业株式会社 2025-03-07 CN disclosed
CN-119528923-A Tri-fused ring compound and preparation method and application thereof 韦恩生物科技有限公司 2025-02-28 CN disclosed
EP-4499224-A1 N-(PYRROLIDIN-3-YL OR PIPERIDIN-4-YL)ACETAMIDE DERIVATIVES Takeda Pharmaceutical Company Limited (JP) 2025-02-05 EP disclosed
WO-2024224093-A1 DESMURAMYLPEPTIDE DIEESTERS AS NOD2 AGONISTS AND USE THEREOF Imhotex Limited (GB) 2024-10-31 WO disclosed
WO-2023187677-A1 N-(PYRROLIDIN-3-YL OR PIPERIDIN-4-YL)ACETAMIDE DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2023-10-05 WO disclosed
US-20050119252-A1 Ligands of melanocortin receptors and compositions and methods related thereto NEUROCRINE BIOSCIENCES, INC. (US) 2005-06-02 US disclosed
WO-2005042516-A2 LIGANDS OF MELANOCORTIN RECEPTORS AND COMPOSITIONS AND METHODS RELATED THERETO NEUROCRINE BIOSCIENCES, INC. (US) 2005-05-12 WO disclosed
US-5179229-A Preparation of 2,2-diorgano-3-arylpropionic acids and esters thereof HOECHST CELANESE CORPORATION (US) 1993-01-12 US disclosed
US-4898608-A Pyridylthio-acylanilide herbicides BAYER AKTIENGESELLSCHAFT (DE) 1990-02-06 US disclosed
US-4797146-A INSECTICIDES, FUNGICIDES BAYER AKTIENGESELLSCHAFT (DE) 1989-01-10 US disclosed
US-4627871-A Herbicidal 2-[4-substituted carboxyamino-phenoxy (or phenyl mercapto)]-substituted pyrimidines BAYER AKTIENGESELLSCHAFT (DE) 1986-12-09 US disclosed
US-4166131-A ANTIINFLAMMATORY AGENTS, ANTIPYRETICS, ANTIARTHRITIC AGENT HEXACHIMIE SOCIETE ANONYME (FR) 1979-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250188037-A1 N-(PYRROLIDIN-3-YL OR PIPERIDIN-4-YL)ACETAMIDE DERIVATIVES SSTR4, SSTR3, SSTR1 GRN 696/4885SORT1 2092/4885PTGES2 2118/4885
US-20050119252-A1 Ligands of melanocortin receptors and compositions and methods related thereto MC3R, MC1R, MC4R GRN 2693/4885SORT1 1790/4885PTGES2 3463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.